ERNA

Ernexa Therapeutics Inc. (ERNA) ESG Analysis Analysis (2026)

Invetso Score: 5.6/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.2 (Moderate)

ERNA shows limited disclosed environmental intensity data, which weakens peer comparability versus larger peers with more complete emissions and resource reporting.

Zero reported R&D-to-revenue does not indicate environmental leadership, but it also suggests no clear evidence of heavy process-related environmental burden versus peers.

The absence of disclosed gross margin and FCF metrics limits assessment of capital available for decarbonization, leaving ERNA broadly in line with disclosure-light peers.

Low leverage can reduce near-term environmental compliance pressure, yet it does not by itself create an environmental advantage versus peers with stronger sustainability disclosure.

Social

Score:

ERNA’s available metrics provide little direct evidence on workforce, safety, or customer-related social practices, leaving its social positioning difficult to distinguish from peers.

Zero stock-based compensation to revenue may indicate limited equity-linked dilution, but it does not materially demonstrate stronger employee alignment than peer companies.

Sparse disclosed operating metrics reduce transparency on labor and community impacts, which is a relative weakness versus peers with fuller social reporting.

No disclosed indicators suggest a major social controversy, so ERNA appears broadly average rather than structurally weaker than peers.

Governance

Score:

ERNA’s low debt-to-equity ratio of 0.11 and net debt-to-EBITDA of 0.27 suggest conservative balance-sheet governance relative to more levered peers.

Zero stock-based compensation to revenue indicates restrained equity dilution, which supports shareholder-alignment discipline versus peers with heavier compensation loads.

However, the limited disclosure set prevents strong assessment of board oversight, audit quality, and executive accountability, keeping governance below leading peers.

Overall governance appears cleaner than highly levered or dilution-heavy peers, but not strong enough to indicate top-tier governance leadership.

Overall Score

Score:

ERNA appears broadly average versus peers, with modest governance discipline offset by limited ESG disclosure that prevents a stronger relative positioning.

Score Driver: Limited ESG Disclosure And Lack Of Observable Sustainability Metrics

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Ernexa Therapeutics Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →